People · Operator
Named in public records as an officer, director or promoter · active 2008–2025 · Pharmaceuticals, Investment Vehicle, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Horizon Pharma, Inc. | — | Pharmaceuticals | Series D+ | $308.4M | $5.3B | 2010 |
| Helix Holdings I, LLC | — | Investment Vehicle | Series D+ | $235.0M | $764.9M | 2015 |
| Molecular Templates, Inc. | — | Biotechnology | Series B | $130.0M | $215.0M | 2009 |
| Theracos Inc | — | Other Health Care | Series C | $118.1M | $571.6M | 2013 |
| Savanna Biotherapeutics, Inc. | — | Biotechnology | Series B | $37.3M | $61.7M | 2022 |
| Horizon Therapeutics Inc | — | Pharmaceuticals | Series B | $37.0M | $272.0M | 2008 |
Jeffrey W. Bird at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey W. Bird on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Louis C. Bock | 2 | 7 |
| Timothy P. Walbert | 2 | 3 |
| William A. Halter | 1 | 18 |
| Michael L. Speiser | 1 | 9 |
| Noah Knauf | 1 | 9 |
| JEFF BIRD | 1 | 7 |
| Jeffrey Bird | 1 | 5 |
| Jeff Himawan | 1 | 4 |
| Justin Kao | 1 | 4 |
| James Lu | 1 | 3 |
| Michael W. Hall | 1 | 3 |
| Wilfred E. Jaeger | 1 | 3 |
| Gino W. Santini | 1 | 3 |
| Jay Flatley | 1 | 3 |
| Barry M. Schuler | 1 | 3 |
| WILLIAM M. SMITH | 1 | 2 |
| Bruce C. Cozadd | 1 | 2 |
| John G. Curd | 1 | 2 |
| Harold E. Selick | 1 | 2 |
| Roger J. Waltzman | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.